Global Prostate Cancer Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Chemotherapy
1.2.3 Hormonal Therapy
1.2.4 Targeted Therapy
1.2.5 Immunotherapy
1.3 Market by Application
1.3.1 Global Prostate Cancer Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Age Below 55
1.3.3 Age 55-75
1.3.4 Age Above 75
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Prostate Cancer Market Size (2017-2028)
2.2 Prostate Cancer Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Prostate Cancer Market Size by Region (2017-2022)
2.4 Global Prostate Cancer Market Size Forecast by Region (2023-2028)
2.5 Global Top Prostate Cancer Countries Ranking by Market Size
3 Prostate Cancer Competitive by Company
3.1 Global Prostate Cancer Revenue by Players
3.1.1 Global Prostate Cancer Revenue by Players (2017-2022)
3.1.2 Global Prostate Cancer Market Share by Players (2017-2022)
3.2 Global Prostate Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Prostate Cancer Revenue
3.4 Global Prostate Cancer Market Concentration Ratio
3.4.1 Global Prostate Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Revenue in 2021
3.5 Global Prostate Cancer Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Product Solution and Service
3.7 Date of Enter into Prostate Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Prostate Cancer Breakdown Data by Type
4.1 Global Prostate Cancer Historic Revenue by Type (2017-2022)
4.2 Global Prostate Cancer Forecasted Revenue by Type (2023-2028)
5 Global Prostate Cancer Breakdown Data by Application
5.1 Global Prostate Cancer Historic Market Size by Application (2017-2022)
5.2 Global Prostate Cancer Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Prostate Cancer Revenue by Company (2020-2022)
6.2 North America Prostate Cancer Revenue by Type (2017-2028)
6.3 North America Prostate Cancer Revenue by Application (2017-2028)
6.4 North America Prostate Cancer Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Prostate Cancer Revenue by Company (2020-2022)
7.2 Europe Prostate Cancer Revenue by Type (2017-2028)
7.3 Europe Prostate Cancer Revenue by Application (2017-2028)
7.4 Europe Prostate Cancer Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Prostate Cancer Revenue by Company (2020-2022)
8.2 Asia Pacific Prostate Cancer Revenue by Type (2017-2028)
8.3 Asia Pacific Prostate Cancer Revenue by Application (2017-2028)
8.4 Asia Pacific Prostate Cancer Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Prostate Cancer Revenue by Company (2020-2022)
9.2 Latin America Prostate Cancer Revenue by Type (2017-2028)
9.3 Latin America Prostate Cancer Revenue by Application (2017-2028)
9.4 Latin America Prostate Cancer Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Prostate Cancer Revenue by Company (2020-2022)
10.2 Middle East and Africa Prostate Cancer Revenue by Type (2017-2028)
10.3 Middle East and Africa Prostate Cancer Revenue by Application (2017-2028)
10.4 Middle East and Africa Prostate Cancer Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Astellas, Inc.
11.1.1 Astellas, Inc. Company Details
11.1.2 Astellas, Inc. Business Overview
11.1.3 Astellas, Inc. Prostate Cancer Products and Services
11.1.4 Astellas, Inc. Prostate Cancer Revenue in Prostate Cancer Business (2017-2022)
11.1.5 Astellas, Inc. Prostate Cancer SWOT Analysis
11.1.6 Astellas, Inc. Recent Developments
11.2 AstraZeneca plc
11.2.1 AstraZeneca plc Company Details
11.2.2 AstraZeneca plc Business Overview
11.2.3 AstraZeneca plc Prostate Cancer Products and Services
11.2.4 AstraZeneca plc Prostate Cancer Revenue in Prostate Cancer Business (2017-2022)
11.2.5 AstraZeneca plc Prostate Cancer SWOT Analysis
11.2.6 AstraZeneca plc Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Prostate Cancer Products and Services
11.3.4 Johnson & Johnson Prostate Cancer Revenue in Prostate Cancer Business (2017-2022)
11.3.5 Johnson & Johnson Prostate Cancer SWOT Analysis
11.3.6 Johnson & Johnson Recent Developments
11.4 Sanofi S.A
11.4.1 Sanofi S.A Company Details
11.4.2 Sanofi S.A Business Overview
11.4.3 Sanofi S.A Prostate Cancer Products and Services
11.4.4 Sanofi S.A Prostate Cancer Revenue in Prostate Cancer Business (2017-2022)
11.4.5 Sanofi S.A Prostate Cancer SWOT Analysis
11.4.6 Sanofi S.A Recent Developments
11.5 Bristol Myers Squibb (BMS)
11.5.1 Bristol Myers Squibb (BMS) Company Details
11.5.2 Bristol Myers Squibb (BMS) Business Overview
11.5.3 Bristol Myers Squibb (BMS) Prostate Cancer Products and Services
11.5.4 Bristol Myers Squibb (BMS) Prostate Cancer Revenue in Prostate Cancer Business (2017-2022)
11.5.5 Bristol Myers Squibb (BMS) Prostate Cancer SWOT Analysis
11.5.6 Bristol Myers Squibb (BMS) Recent Developments
11.6 Bayer AG
11.6.1 Bayer AG Company Details
11.6.2 Bayer AG Business Overview
11.6.3 Bayer AG Prostate Cancer Products and Services
11.6.4 Bayer AG Prostate Cancer Revenue in Prostate Cancer Business (2017-2022)
11.6.5 Bayer AG Prostate Cancer SWOT Analysis
11.6.6 Bayer AG Recent Developments
12 Prostate Cancer Market Dynamics
12.1 Prostate Cancer Market Trends
12.2 Prostate Cancer Market Drivers
12.3 Prostate Cancer Market Challenges
12.4 Prostate Cancer Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of TablesTable 1. Global Prostate Cancer Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Hormonal Therapy
Table 4. Key Players of Targeted Therapy
Table 5. Key Players of Immunotherapy
Table 6. Global Prostate Cancer Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Prostate Cancer Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Prostate Cancer Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Prostate Cancer Revenue Market Share by Region (2017-2022)
Table 10. Global Prostate Cancer Revenue by Players (2017-2022) & (US$ Million)
Table 11. Global Prostate Cancer Market Share by Players (2017-2022)
Table 12. Global Top Prostate Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer as of 2021)
Table 13. Ranking of Global Top Prostate Cancer Companies by Revenue (US$ Million) in 2021
Table 14. Global 5 Largest Players Market Share by Prostate Cancer Revenue (CR5 and HHI) & (2017-2022)
Table 15. Key Players Headquarters and Area Served
Table 16. Key Players Prostate Cancer Product Solution and Service
Table 17. Date of Key Manufacturers Enter into Prostate Cancer Market
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Prostate Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 20. Global Prostate Cancer Revenue Market Share by Type (2017-2022)
Table 21. Global Prostate Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 22. Global Prostate Cancer Revenue Market Share by Type (2023-2028)
Table 23. Global Prostate Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 24. Global Prostate Cancer Revenue Market Share by Application (2017-2022)
Table 25. Global Prostate Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 26. Global Prostate Cancer Revenue Market Share by Application (2023-2028)
Table 27. North America Prostate Cancer Revenue by Company (2020-2022) & (US$ Million)
Table 28. North America Prostate Cancer Revenue by Type (2017-2022) & (US$ Million)
Table 29. North America Prostate Cancer Revenue by Type (2023-2028) & (US$ Million)
Table 30. North America Prostate Cancer Revenue by Application (2017-2022) & (US$ Million)
Table 31. North America Prostate Cancer Revenue by Application (2023-2028) & (US$ Million)
Table 32. North America Prostate Cancer Revenue by Country (2017-2022) & (US$ Million)
Table 33. North America Prostate Cancer Revenue by Country (2023-2028) & (US$ Million)
Table 34. Europe Prostate Cancer Revenue by Company (2020-2022) & (US$ Million)
Table 35. Europe Prostate Cancer Revenue by Type (2017-2022) & (US$ Million)
Table 36. Europe Prostate Cancer Revenue by Type (2023-2028) & (US$ Million)
Table 37. Europe Prostate Cancer Revenue by Application (2017-2022) & (US$ Million)
Table 38. Europe Prostate Cancer Revenue by Application (2023-2028) & (US$ Million)
Table 39. Europe Prostate Cancer Revenue by Country (2017-2022) & (US$ Million)
Table 40. Europe Prostate Cancer Revenue by Country (2023-2028) & (US$ Million)
Table 41. Asia Pacific Prostate Cancer Revenue by Company (2020-2022) & (US$ Million)
Table 42. Asia Pacific Prostate Cancer Revenue by Type (2017-2022) & (US$ Million)
Table 43. Asia Pacific Prostate Cancer Revenue by Type (2023-2028) & (US$ Million)
Table 44. Asia Pacific Prostate Cancer Revenue by Application (2017-2022) & (US$ Million)
Table 45. Asia Pacific Prostate Cancer Revenue by Application (2023-2028) & (US$ Million)
Table 46. Asia Pacific Prostate Cancer Revenue by Region (2017-2022) & (US$ Million)
Table 47. Asia Pacific Prostate Cancer Revenue by Region (2023-2028) & (US$ Million)
Table 48. Latin America Prostate Cancer Revenue by Company (2020-2022) & (US$ Million)
Table 49. Latin America Prostate Cancer Revenue by Type (2017-2022) & (US$ Million)
Table 50. Latin America Prostate Cancer Revenue by Type (2023-2028) & (US$ Million)
Table 51. Latin America Prostate Cancer Revenue by Application (2017-2022) & (US$ Million)
Table 52. Latin America Prostate Cancer Revenue by Application (2023-2028) & (US$ Million)
Table 53. Latin America Prostate Cancer Revenue by Country (2017-2022) & (US$ Million)
Table 54. Latin America Prostate Cancer Revenue by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Prostate Cancer Revenue by Company (2020-2022) & (US$ Million)
Table 56. Middle East and Africa Prostate Cancer Revenue by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Prostate Cancer Revenue by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Prostate Cancer Revenue by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Prostate Cancer Revenue by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Prostate Cancer Revenue by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Prostate Cancer Revenue by Country (2023-2028) & (US$ Million)
Table 62. Astellas, Inc. Company Details
Table 63. Astellas, Inc. Business Overview
Table 64. Astellas, Inc. Prostate Cancer Product and Services
Table 65. Astellas, Inc. Prostate Cancer Revenue in Prostate Cancer Business (2017-2022) & (US$ Million)
Table 66. Astellas, Inc. Prostate Cancer SWOT Analysis
Table 67. Astellas, Inc. Recent Developments
Table 68. AstraZeneca plc Company Details
Table 69. AstraZeneca plc Business Overview
Table 70. AstraZeneca plc Prostate Cancer Product and Services
Table 71. AstraZeneca plc Prostate Cancer Revenue in Prostate Cancer Business (2017-2022) & (US$ Million)
Table 72. AstraZeneca plc Prostate Cancer SWOT Analysis
Table 73. AstraZeneca plc Recent Developments
Table 74. Johnson & Johnson Company Details
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Prostate Cancer Product and Services
Table 77. Johnson & Johnson Prostate Cancer Revenue in Prostate Cancer Business (2017-2022) & (US$ Million)
Table 78. Johnson & Johnson Prostate Cancer SWOT Analysis
Table 79. Johnson & Johnson Recent Developments
Table 80. Sanofi S.A Company Details
Table 81. Sanofi S.A Business Overview
Table 82. Sanofi S.A Prostate Cancer Product and Services
Table 83. Sanofi S.A Prostate Cancer Revenue in Prostate Cancer Business (2017-2022) & (US$ Million)
Table 84. Sanofi S.A Prostate Cancer SWOT Analysis
Table 85. Sanofi S.A Recent Developments
Table 86. Bristol Myers Squibb (BMS) Company Details
Table 87. Bristol Myers Squibb (BMS) Business Overview
Table 88. Bristol Myers Squibb (BMS) Prostate Cancer Product and Services
Table 89. Bristol Myers Squibb (BMS) Prostate Cancer Revenue in Prostate Cancer Business (2017-2022) & (US$ Million)
Table 90. Bristol Myers Squibb (BMS) Prostate Cancer SWOT Analysis
Table 91. Bristol Myers Squibb (BMS) Recent Developments
Table 92. Bayer AG Company Details
Table 93. Bayer AG Business Overview
Table 94. Bayer AG Prostate Cancer Product and Services
Table 95. Bayer AG Prostate Cancer Revenue in Prostate Cancer Business (2017-2022) & (US$ Million)
Table 96. Bayer AG Prostate Cancer SWOT Analysis
Table 97. Bayer AG Recent Developments
Table 98. Prostate Cancer Market Trends
Table 99. Prostate Cancer Market Drivers
Table 100. Prostate Cancer Market Challenges
Table 101. Prostate Cancer Market Restraints
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Prostate Cancer Sales Market Share by Type: 2021 VS 2028
Figure 2. Chemotherapy Features
Figure 3. Hormonal Therapy Features
Figure 4. Targeted Therapy Features
Figure 5. Immunotherapy Features
Figure 6. Global Prostate Cancer Sales Market Share by Application: 2021 VS 2028
Figure 7. Age Below 55 Case Studies
Figure 8. Age 55-75 Case Studies
Figure 9. Age Above 75 Case Studies
Figure 10. Prostate Cancer Report Years Considered
Figure 11. Global Prostate Cancer Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Prostate Cancer Market Size 2017-2028 (US$ Million)
Figure 13. Global Prostate Cancer Market Size Market Share by Region: 2021 VS 2028
Figure 14. Global Prostate Cancer Revenue Market Share by Region in 2017 VS 2022
Figure 15. Global Top 10 Prostate Cancer Countries Ranking by Market Size (US$ Million) in 2021
Figure 16. Global Prostate Cancer Market Share by Players in 2021
Figure 17. Global Top Prostate Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Prostate Cancer Revenue in 2021
Figure 19. North America Prostate Cancer Revenue Market Share by Company in 2021
Figure 20. North America Prostate Cancer Revenue Market Share by Type (2017-2028)
Figure 21. North America Prostate Cancer Revenue Market Share by Application (2017-2028)
Figure 22. North America Prostate Cancer Revenue Share by Country (2017-2028)
Figure 23. U.S. Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 24. Canada Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 25. Europe Prostate Cancer Revenue Market Share by Company in 2021
Figure 26. Europe Prostate Cancer Revenue Market Share by Type (2017-2028)
Figure 27. Europe Prostate Cancer Revenue Market Share by Application (2017-2028)
Figure 28. Europe Prostate Cancer Revenue Share by Country (2017-2028)
Figure 29. Germany Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 30. France Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 31. U.K. Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 32. Italy Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 33. Russia Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Prostate Cancer Revenue Market Share by Company in 2021
Figure 35. Asia Pacific Prostate Cancer Revenue Market Share by Type (2017-2028)
Figure 36. Asia Pacific Prostate Cancer Revenue Market Share by Application (2017-2028)
Figure 37. Asia Pacific Prostate Cancer Revenue Share by Region (2017-2028)
Figure 38. China Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 39. Japan Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 40. South Korea Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 41. India Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 42. Australia Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 43. Taiwan Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 44. Indonesia Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 45. Thailand Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 46. Malaysia Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 47. Philippines Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 48. Vietnam Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 49. Latin America Prostate Cancer Revenue Market Share by Company in 2021
Figure 50. Latin America Prostate Cancer Revenue Market Share by Type (2017-2028)
Figure 51. Latin America Prostate Cancer Revenue Market Share by Application (2017-2028)
Figure 52. Latin America Prostate Cancer Revenue Share by Country (2017-2028)
Figure 53. Mexico Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 54. Brazil Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 55. Argentina Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 56. Middle East and Africa Prostate Cancer Revenue Market Share by Company in 2021
Figure 57. Middle East and Africa Prostate Cancer Revenue Market Share by Type (2017-2028)
Figure 58. Middle East and Africa Prostate Cancer Revenue Market Share by Application (2017-2028)
Figure 59. Middle East and Africa Prostate Cancer Revenue Share by Country (2017-2028)
Figure 60. Turkey Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 61. Saudi Arabia Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 62. U.A.E Prostate Cancer Revenue (2017-2028) & (US$ Million)
Figure 63. Astellas, Inc. Revenue Growth Rate in Prostate Cancer Business (2017-2022)
Figure 64. AstraZeneca plc Revenue Growth Rate in Prostate Cancer Business (2017-2022)
Figure 65. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Business (2017-2022)
Figure 66. Sanofi S.A Revenue Growth Rate in Prostate Cancer Business (2017-2022)
Figure 67. Bristol Myers Squibb (BMS) Revenue Growth Rate in Prostate Cancer Business (2017-2022)
Figure 68. Bayer AG Revenue Growth Rate in Prostate Cancer Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed